LRMR logo

Larimar Therapeutics, Inc. (LRMR)

Profile

Full Name

Larimar Therapeutics, Inc.

Ticker

NASDAQ: LRMR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 19, 2014

Indexes

Not included

Website

https://larimartx.com

Employees

65

Key Details

Price

$3.65(-6.41%)

Market cap

$302.14M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$1.32(-57.14% YoY)

PE ratio

-

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.65
    LRMR price is $3.65

    30-Day Relative Volume

    1.05
    LRMR 30-day relative volume is 1.05

    Price Performance

    Price Today change

    -6.41%
    LRMR price is down -6.41% today

    Price YTD change

    -5.68%
    LRMR price is down -5.68% since January 1st

    Price 1-year change

    -53.74%
    LRMR price is down -53.74% year-on-year

    Price 3-year change

    +21.67%
    LRMR price is up +21.67% over the past 3 years

    Price Range

    Price All-time high

    $55.36
    LRMR price is currently -93.41% below its historical high of $55.36

    Price 3-year low

    $1.61
    LRMR price is currently +126.71% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $302.14M
    LRMR market capitalization is $302.14 million

    Market cap 3-year change

    +468.66%
    LRMR market capitalization is up +468.66% over the past 3 years

    Market cap All-time high

    $681.41M
    LRMR market capitalization is currently -55.66% below its historical high of $681.41 million

    Market cap sector rank

    58.13%
    LRMR market capitalization is higher than 58.13% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +29.73%
    LRMR shares outstanding is up +29.73% year-on-year

    Shares Outstanding 3-Year Change

    +367.39%
    LRMR shares outstanding is up +367.39% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.47
    LRMR beta is 1.47

    200-day SMA

    $3.63
    LRMR price is currently +0.48% above its 200-day simple moving average

    50-day SMA

    $3.32
    LRMR price is currently +9.84% above its 50-day simple moving average

    RSI

    51.39
    LRMR 14-day relative strength index is 51.39

    Volume

    1.05
    LRMR 30-day relative volume is 1.05

    ATR

    $0.36
    LRMR average true range is $0.36

    10-day Historical Volatility

    98.12%
    LRMR 10-day historical volatility is 98.12%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    LRMR annual revenue is $0.00

    Revenue Analysts estimate

    -
    LRMR annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    LRMR annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.58%
    LRMR annual revenue is higher than 28.58% of companies in Healthcare sector

    EPS

    EPS

    -$1.32
    LRMR annual earnings per share is -$1.32

    EPS Analysts estimate

    -$1.70
    LRMR annual earnings per share is currently -22.41% lower than the consensus analysts' forecast

    EPS 1-year change

    -57.14%
    LRMR annual earnings per share is down -57.14% year-on-year

    EPS Sector rank

    45.43%
    LRMR annual earnings per share is higher than 45.43% of companies in Healthcare sector

    Profit

    Gross profit

    -$318.00K
    LRMR annual gross profit is -$318.00 thousand

    Gross margin

    -
    LRMR annual gross profit margin value is unknown

    Operating profit

    -$90.89M
    LRMR annual operating income is -$90.89 million

    Operating margin

    -
    LRMR annual operating profit margin value is unknown

    Net income

    -$80.60M
    LRMR annual net profit is -$80.60 million

    Net margin

    -
    LRMR annual net profit margin value is unknown

    Expenses

    Total expenses

    $80.60M
    LRMR annual total expenses is $80.60 million

    Operating expenses

    $90.57M
    LRMR annual total operating expenses is $90.57 million

    Cost of goods sold

    $318.00K
    LRMR annual cost of goods sold is $318.00 thousand

    Selling, general & administrative expenses

    $0.00
    LRMR annual SGA is $0.00

    Depreciation and amortization

    $318.00K
    LRMR annual depreciation & amortization is $318.00 thousand

    Interest expense

    $0.00
    LRMR annual interest expense is $0.00

    Income tax

    $0.00
    LRMR annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$90.89M
    LRMR annual earnings before interest & taxes is -$90.89 million

    EBITDA

    -$90.57M
    LRMR annual EBITDA is -$90.57 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $200.93M
    LRMR annual total assets is $200.93 million

    Non current assets

    $5.63M
    LRMR annual long term assets is $5.63 million

    Current assets

    $195.30M
    LRMR annual total current assets is $195.30 million

    Cash and cash equivalents

    $183.45M
    LRMR annual cash & cash equivalents is $183.45 million

    Accounts receivable

    -
    LRMR annual accounts receivable value is unknown

    Inventory

    $0.00
    LRMR annual inventory is $0.00

    Liabilities

    Total liabilities

    $29.12M
    LRMR annual total liabilities is $29.12 million

    Long term liabilities

    $4.76M
    LRMR annual total long term liabilities is $4.76 million

    Current liabilities

    $24.36M
    LRMR annual total current liabilities is $24.36 million

    Accounts payable

    $2.42M
    LRMR annual accounts payable is $2.42 million

    Debt

    Total debt

    $5.12M
    LRMR annual total debt is $5.12 million

    Total debt 1-year change

    -7.74%
    LRMR annual total debt is down -7.74% year-on-year

    Long term debt

    $4.06M
    LRMR annual long term debt is $4.06 million

    Short term debt

    $1.06M
    LRMR annual short term debt is $1.06 million

    Equity & Capital

    Shareholders equity

    $171.81M
    LRMR annual stockholders equity is $171.81 million

    Book value

    $171.81M
    LRMR annual book value is $171.81 million

    Retained earnings

    -$269.16M
    LRMR annual retained earnings is -$269.16 million

    Working capital

    $170.95M
    LRMR annual working capital is $170.95 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$70.76M
    LRMR annual cash flow from operations is -$70.76 million

    Cash from operations 1-year change

    -111.48%
    LRMR annual cash flow from operations is down -111.48% year-on-year

    Cash from investing

    -$85.39M
    LRMR annual cash flow from investing activities is -$85.39 million

    Cash from investing 1-year change

    -356.01%
    LRMR annual cash flow from investing activities is down -356.01% year-on-year

    Cash from financing

    $161.88M
    LRMR annual cash flow from financing activities is $161.88 million

    Cash from financing 1-year change

    +539510%
    LRMR annual cash flow from financing activities is up +539510% year-on-year

    CAPEX

    CAPEX

    $515.00K
    LRMR annual capital expenditures is $515.00 thousand

    CAPEX 1-year change

    +214.02%
    LRMR annual capital expenditures is up +214.02% year-on-year

    Free Cash Flow

    Free cash flow

    -$71.28M
    LRMR annual free cash flow is -$71.28 million

    Free cash flow 1-year change

    -111.98%
    LRMR annual free cash flow is down -111.98% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    LRMR annual gross profit margin value is unknown

    Operating margin

    -
    LRMR annual operating profit margin value is unknown

    Net margin

    -
    LRMR annual net profit margin value is unknown

    ROA & ROE

    ROA

    -54.30%
    LRMR annual return on assets is -54.30%

    ROE

    -63.58%
    LRMR annual return on equity is -63.58%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    LRMR price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    LRMR price to earnings ratio is unknown

    PB Ratio

    PB ratio

    2.52
    LRMR price to book ratio is 2.52

    PB ratio Sector rank

    62.26%
    LRMR price to book ratio is higher than 62.26% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    LRMR price to sales ratio value is unknown

    PS ratio Sector rank

    -
    LRMR price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $163.62M
    LRMR enterprise value is $163.62 million

    Enterprise value Sector rank

    55.18%
    LRMR enterprise value is higher than 55.18% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.51
    LRMR EV/EBITDA is -1.51

    EV/EBITDA Sector rank

    37.94%
    LRMR EV/EBITDA is higher than 37.94% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    8.02
    LRMR annual current ratio is 8.02

    Quick ratio

    8.02
    LRMR annual quick ratio is 8.02

    Leverage

    Debt to equity

    0.03
    LRMR annual debt to equity ratio is 0.03

    Interest coverage ratio

    -
    LRMR annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    LRMR piotroski f-score value is unknown

    Altman Z-Score

    3.88
    LRMR altman z-score is 3.88

    Analyst ratings

    Recent major analysts updates

    Aug 15, 25 JMP Securities
    Market Outperform
    Jun 25, 25 Guggenheim
    Buy
    Jun 24, 25 Wedbush
    Outperform
    Jun 24, 25 Guggenheim
    Buy
    Mar 25, 25 HC Wainwright & Co.
    Buy
    Mar 25, 25 Guggenheim
    Buy
    Mar 25, 25 Baird
    Outperform
    Jan 29, 25 Truist Securities
    Buy
    Jan 24, 25 HC Wainwright & Co.
    Buy
    Dec 17, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with LRMR included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Larimar Therapeutics, Inc.?
    • Does Larimar Therapeutics, Inc. pay dividends?
    • What sector is Larimar Therapeutics, Inc. in?
    • What industry is Larimar Therapeutics, Inc. in?
    • What country is Larimar Therapeutics, Inc. based in?
    • When did Larimar Therapeutics, Inc. go public?
    • Is Larimar Therapeutics, Inc. in the S&P 500?
    • Is Larimar Therapeutics, Inc. in the NASDAQ 100?
    • Is Larimar Therapeutics, Inc. in the Dow Jones?
    • When was Larimar Therapeutics, Inc.'s last earnings report?
    • When does Larimar Therapeutics, Inc. report earnings?

    What is the ticker symbol for Larimar Therapeutics, Inc.?

    The ticker symbol for Larimar Therapeutics, Inc. is NASDAQ:LRMR

    Does Larimar Therapeutics, Inc. pay dividends?

    No, Larimar Therapeutics, Inc. does not pay dividends

    What sector is Larimar Therapeutics, Inc. in?

    Larimar Therapeutics, Inc. is in the Healthcare sector

    What industry is Larimar Therapeutics, Inc. in?

    Larimar Therapeutics, Inc. is in the Biotechnology industry

    What country is Larimar Therapeutics, Inc. based in?

    Larimar Therapeutics, Inc. is headquartered in United States

    When did Larimar Therapeutics, Inc. go public?

    Larimar Therapeutics, Inc.'s initial public offering (IPO) was on June 19, 2014

    Is Larimar Therapeutics, Inc. in the S&P 500?

    No, Larimar Therapeutics, Inc. is not included in the S&P 500 index

    Is Larimar Therapeutics, Inc. in the NASDAQ 100?

    No, Larimar Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Larimar Therapeutics, Inc. in the Dow Jones?

    No, Larimar Therapeutics, Inc. is not included in the Dow Jones index

    When was Larimar Therapeutics, Inc.'s last earnings report?

    Larimar Therapeutics, Inc.'s most recent earnings report was on August 14, 2025

    When does Larimar Therapeutics, Inc. report earnings?

    The next expected earnings date for Larimar Therapeutics, Inc. is November 6, 2025
    On this page